Journal
FUTURE MICROBIOLOGY
Volume 9, Issue 6, Pages 725-735Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FMB.14.33
Keywords
biofilm; bioluminescence; quantitation; safranine; Staphylococcus aureus
Categories
Ask authors/readers for more resources
Aim: To quantitatively assess Staphylococcus aureus biofilms. Materials & methods: In addition to the qualitative Congo red agar (CRA) method, we used the bioluminescence (BLM), safranine (SAF), crystal violet (CRV) and resazurin (RES) high-throughput microtiter plate-based quantitative assays. Results: 60.47% (26/43) of S. aureus clinical isolates were weak biofilm producers. The CRA method detected positive-slime phenotypes (13.95%), but was unable to distinguish weak from negative producers. BLM assays demonstrated significant correlations with RES (highest), CRV and SAF (lowest). Lower coefficient of variation values indicate precision. BLM scored highest precision (coefficient of variation = 0.013) followed by RES, SAF and CRV. Conclusion: BLM and RES detect live biomass in S. aureus biofilms (for physiological studies). SAF and CRV detect live/dead bacteria plus biofilm matrix (for monitoring overall biofilm architecture, not only its cell viability). Reliable assays are essential for effective biofilm therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available